Connect to other sites within the UBM Medica Network
Low-dose Opioids Safe for Severe COPD
While high-dose opioids may be deadly, lower doses may be safe for symptom reduction in severe respiratory disease. For those with milder COPD, a new treatment is in testing.
Preventing COPD Exacerbations by Restoring Antiviral Response
High doses of N-acetylcysteine improve small airway function in patients with COPD. The unresolved question is why.
Drug Offers Novel Approach for Airway Diseases
For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.
COPD Exacerbations Reduced With Short Corticosteroid Course
Patients respond to 5 days of corticosteroid therapy just as well as to 14 days of therapy, according to a study.
An Unusual Presentation of Septic Hip
Emphysematous cholecystitis is a rare condition that is the result of infection with Clostridium perfringens and other gas-producing organisms including Escherichia coli, Bacteroides fragilis, and Klebsiella species.
Higher Stroke Risk in Older Patients With COPD
Older patients with chronic obstructive pulmonary disease are at higher risk for plaque formation in the carotid artery, increasing their risk of stroke.
Pulmonary Disease Questionnaire to Boost Diagnoses
Diagnoses of chronic obstructive pulmonary disease may increase with the use of a 5-question patient-administered survey.